Tachykinins And Their Receptors In The Lung

Handbook of Biologically Active Peptides

Volumn , Issue , 2006, Pages 1301-1305

  Meini, Stefania ^a   Lecci, Alessandro ^a  

^a Dept of Pharmacology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35648957397     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369442-3/50183-5     Document Type: Chapter

References (32)

1. Almeida TA, Rojo J, Pinto FM, Hernandez M, Martín JD, Candenas ML Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem 2004, 11:2045-2081.
2. Barnes PJ Inflammatory mediators of asthma: an update. Pharmacol Rev 1998, 50:515-596.
3. Beaujouan J-C, Torrens Y, Saffroy M, Kemel ML, Glowinskin J A 25 year adventure in the field of tachykinins. Peptides 2004, 25:339-357.
4. Boschetto P, Miotto D, Bonomi I, Faggian D, Plebani M, Papi A, Creminon C, De Rosa E, Fabbri LM, Mapp CE Sputum substance P and neurokinin A are reduced during exacerbations of chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2005, 18:199-205.
5. Chavolla-Calderon M, Bayer MK, Fontan JJ Bone marrow transplantation reveals an essential synergy between neuronal and hemopoietic cell neurokinin production in pulmonary inflammation. J Clin Invest 2003, 111:973-980.
6. 2 receptor antagonists on tachykinergic bronchomotor responses in guinea-pig. Auton Autacoid Pharmacol 2003, 23:79-93.
7. Crimi N, Pagano C, Palermo F, Mastruzzo C, Prosperini G, Pistorio MP, Vancheri C Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction. J Allergy Clin Immunol 2003, 111:833-839.
8. Crummy F, Livingston M, Ardill JES, Adamson C, Ennis M, Heaney LG Mast cell mediator release in nonasthmatic subjects after endobronchial adenosine challenge. J Allergy Clin Immunol 2004, 114:34-39.
9. Daoui S, Cognon C, Naline E, Emonds-Alt X, Advenier C Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea pigs. Am J Respir Crit Care Med 1998, 158:42-48.
10. Daoui S, Cui YY, Lagente V, Emonds-Alt X, Advenier C A tachykinin NK3 receptor antagonist, SR 142801 (osanetant), prevents substance P-induced bronchial hyperreactivity in guinea-pigs. Pulm Pharmacol Ther 1997, 10:261-270.
11. DeFea KA, Vaughn ZD, O'Brian EM, Nishijima D, Déry O, Bunnett NW The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA 2000, 97:11086-11091.
12. Fahy JV, Wong HH, Geppetti P, Reis JM, Harris SC, Maclean DB, Nadel JA, Boushey HA Effect of an NK1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects. Am J Respir Crit Care Med 1995, 152:879-884.
13. Foord SM, Bonneer TI, Neubig RR, Rosser EM, Pinn J-P, Davenport AP, Spedding M, Harmar AJ International union of pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 2005, 57:279-288.
14. Harrison NK, Dawes KE, Kwon OJ, Barnes PJ, Laurent GJ, Chung KF Effects of neuropeptides on human lung fibroblasts proliferation and chemotaxis. Am J Physiol 1995, 268:L278-L283.
15. Hay DW, Giardina GA, Griswold DE, et al. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor receptor antagonist, inhibits citric acid-induced cough and airways hyperreactivity in guinea pigs. J Pharmacol Exp Ther 2002, 300:314-323.
16. Ichinose M, Miura M, Yamauchi H, Kageyama N, Tomaki M, Oyake T, Ohuchi Y, Hida W, Miki H, Tamura G, Shirato K A neurokinin 1-receptor antagonist improves exercise-induced aiway narrowing in asthmatic patients. Am J Respir Crit Care Med 1996, 159:936-941.
17. Joos GF, De Swert KO, Pauwels RA Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists. Eur J Pharmacol 2001, 429:239-250.
18. Joos GF, Vinken W, Louis R, Schelfout VJ, Wang JH, Shaw WJ, Cioppa GD, Pauwels RA Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients. Eur Resp J 2004, 23:76-81.
19. Kenakin T Agonist-receptor efficacy: agonist trafficking of receptor signals. Trends Pharmacol Sci 1995, 16:232-238.
20. Kraan J, Vink-Klooster H, Postma DS The NK-2 receptor antagonist SR 48968C does not improve adenosine hyperresponsiveness and airway obstruction in allergic asthma. Clin Exp Allergy 2001, 31:274-278.
21. Lecci A, Maggi CA Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases. Expert Opin Ther Targets 2003, 7:343-362.
22. Martini L, Hastrup H, Holst B, Fraile-Ramos A, Marsh M, Schwartz TW NK1 receptor fused to β-arrestin displays a single-component, high affinity molecular phenotype. Mol Pharmacol 2002, 62:30-37.
23. Mukaiyama O, Morimoto K, Nosaka E, Takahashi S, Yamashita M Involvement of enhanced neurokinin NK3 receptor expression in the severe asthma guinea pig model. Eur J Pharmacol 2004, 498:287-294.
24. Myers AC, Goldie RG, Hay DWP A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial ganglia neurons. Am J Resp Crit Care Med 2005, 171:212-216.
25. Myers AC, Kajekar R, Undem BJ Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am J Physiol Lung Cell Mol Physiol 2002, 282:L775-L781.
26. Nenan S, Germain N, Lagente V, Emonds-Alt X, Advenier C, Boichot E Inhibition of inflammatory cell recruitment by the tachykinin NK(3)-receptor antagonist, SR 142801, in a murine model of asthma. Eur J Pharmacol 2001, 421:201-205.
27. Page NM Hemokinins and endokinins. Cell Mol Life Sci 2004, 61:1652-1663.
28. Pinto FM, Almeida TA, Hernandez M, Devillier P, Advenier C, Candenas ML mRNA expression of tachykinins and tachykinin receptors in different human tissues. Eur J Pharmacol 2004, 494:233-239.
29. Tagawa A, Kaneko T, Nishiyama H, Shinohara T, Sato T, Geppetti P, Ishigatsubo Y Cigarette smoke increases mucosal permeability in guinea pig trachea via tachykinin NK2 receptor activation. Eur J Pharmacol 2005, 507:223-228.
30. Van Rensen EL, Hiemstra PS, Rabe KF, Sterk PJ Assessment of microvascular leakage via sputum induction: the role of substance P and neurokinin A in patients with asthma. Am J Respir Crit Care Med 2002, 165:1275-1279.
31. Van Schoor J, Joos GF, Chasson BL, Brouard RJ, Pauwels RA The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics. Eur Respir J 1998, 12:17-23.
32. Van Schoor J, Joos GF, Pauwels RA Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma. Eur Respir J 2002, 19:997-1002.